Single-Photon Emission Computed Tomography Market Research Report – Forecast till 2030

Single-Photon Emission Computed Tomography (SPECT) Market Research Report, By Type (Hybrid SPECT Systems, Standalone SPECT Systems), Application (Oncology, Cardiology, Neurology), End-User (Hospitals, Diagnostic Imaging Centers)-Forecast Till 2030

ID: MRFR/HC/5764-HCR | February 2023 | Region: Global | 90 Pages         

Single-Photon Emission Computed Tomography Market Speak to Analyst Request a Free Sample

Single-Photon Emission Computed Tomography (SPECT) Market

The global Single-Photon Emission Computed Tomography (SPECT) global market size is projected to register a CAGR of 6.9% over the forecast period.

Segmentation
By Type Hybrid SPECT Systems Standalone SPECT Systems
By Application Oncology Cardiology Neurology
By End-User Hospitals Diagnostic Imaging Centres
Key Players
Companies Profiled   GE Healthcare   Siemens Healthcare   Koninklijke Philips N.V.   Bruker Corporation   Mediso Ltd.   Digirad Corporation   Spectrum Dynamics Medical   DDD-Diagnostic A/S   MiE America Inc.   CardiArc
Drivers
Market Driving Forces   Growing geriatric population   Improvements in spect imaging technology   Shorter half-life of radioisotopes   Huge capital investment    and stringent regulatory guidelines
Request a Free Sample

Single-Photon Emission Computed Tomography Market Overview:


The Single-Photon Emission Computed Tomography market is projected to reach USD 1.93 Billion  by 2030 at 6.10% CAGR during the forecast period 2022-2030.


The single-photon emission computed tomography is used to evaluate the disease processes based on the functional and metabolic information of the organs and cells. The most widely used single-photon emission computed tomography systems are based on the anger gamma camera, usually involving the dual detectors that rotate around the patient. The application of hybrid equipment and fused techniques has increased the importance in the field of imaging diagnostics. One of the most significant advantages of these methods is the simultaneous use of several modalities, which can give data about the morphological, functional and molecular changes of the different diseases simultaneously.


However, there is an increasing trend of dual-modality systems and organ-specific systems to enhance the diagnostic capability of the equipment. In the last few years, there has been growing the utilization of the computed tomography due to the fact that functional and morphologic correlative images produced by this methodology improve the diagnostic accuracy, and it is one of the primary factors that can impede the growth of the single-photon emission computed tomography equipment market. However, due to all the factors mentioned above, the market is expected to witness good growth over the forecast period.Segmentation


The Single-Photon Emission Computed Tomography (SPECT) global market is segmented on the basis of type, application, end-users. The Single-Photon Emission Computed Tomography (SPECT) market, by type, the market is segmented into hybrid SPECT systems, and standalone SPECT systems. On the basis of application, the Single-Photon Emission Computed Tomography (SPECT) market is bifurcated into oncology, cardiology, neurology, and others. On the basis of end-user, the market is segmented into hospitals, diagnostic imaging centres, academic & research centres, and others.


On the basis of region, the global Single-Photon Emission Computed Tomography (SPECT) market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.


Key players


Some of the key players in the global Single-Photon Emission Computed Tomography (SPECT) market are GE Healthcare, Siemens Healthcare, Koninklijke Philips N.V., Bruker Corporation, Mediso Ltd., Digirad Corporation, Spectrum Dynamics Medical, DDD-Diagnostic A/S, MiE America, Inc., CardiArc, Beijing Hamamatsu Photon Techniques INC., SHENZHEN BASDA MEDICAL APPARATUS CO., LTD., PNPMedM, NuCare Inc., and others.


Regional Market Summary:


Single-Photon Emission Computed Tomography (SPECT) Global Market Share (%), by Region, 2017


Single-Photon Emission Computed Tomography Market  Share


Sources: Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), US Department of Health and Human Services, National Institutes of Health, Company’s Annual Report


The Americas region dominated the Single-Photon Emission Computed Tomography (SPECT) global market in 2017, owing to the presence of major market participants & sophisticated healthcare infrastructure and comparatively higher adoption of advanced nuclear medicine tomographic imaging techniques in the U.S. and Canada.


Europe hoisted as the second largest region for the global Single-Photon Emission Computed Tomography (SPECT) global market owing to increasing awareness of disease-causing deformities along with the rise in the number of numerous surgeries is are expected to provide this market with lucrative growth opportunities.


Asia-Pacific was projected to be the fastest growing region for the global Single-Photon Emission Computed Tomography (SPECT) global market in 2017. The factors attributed to the due to the growing aging population along with a surge in the incidence of chronic diseases, rising awareness about technique, and increasing healthcare spending in China, India, and Japan.


The Middle East and Africa holds the least share in the Single-Photon Emission Computed Tomography (SPECT) global market due to the presence of poor health expenditure and economically diverse countries. However, the market is expected to witness growth due to increasing healthcare programs in the Middle East.


Market Segmentation and Key Market Players


 Global Single-Photon Emission Computed Tomography (SPECT) Market, by Type



  • Hybrid SPECT Systems

  • Standalone SPECT Systems


Global Single-Photon Emission Computed Tomography (SPECT) Market, by Application



  • Oncology

  • Cardiology

  • Neurology

  • Others


Global Single-Photon Emission Computed Tomography (SPECT) Market, by End User



  • Hospitals

  • Diagnostic Imaging Centers

  • Academic & Research Centers

  • Others


Global Single-Photon Emission Computed Tomography (SPECT) Market, by Region



  • Americas

  • Europe

  • Asia-Pacific

  • Middle East & Africa


Global Single-Photon Emission Computed Tomography (SPECT) Market, by Key Players



  • GE Healthcare

  • Siemens Healthcare

  • Koninklijke Philips N.V.

  • Bruker Corporation

  • Mediso Ltd.

  • Digirad Corporation

  • Spectrum Dynamics Medical

  • DDD-Diagnostic A/S

  • MiE America, Inc.

  • CardiArc

  • Beijing Hamamatsu Photon Techniques INC.,

  • SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.

  • PNPMedM

  • NuCare Inc.



Recent DevelopmentJuly 2020


Additionally, the introduction of the new products in the market is also boosting the growth of the market in the region. For instance, in July 2020, Spectrum Dynamics Medical introduced a digital solid-state cadmium zinc telluride based cardiac single-photon emission computed tomography system called D-SPECT Vista. The system can be used for myocardial perfusion imaging.


September 2020


In September 2020, Siemens healthiness introduced a new version of its c.cam dedicated cardiac nuclear medicine system to the US market.Intended Audience



  • Medical device companies

  • Clinical institutes

  • Government and private laboratories

  • Research and Development (R&D) companies

  • Medical research laboratories

  • Market research and consulting service providers




Report Scope:

Report Attribute/Metric Details
  Market Size   Significant Value
  CAGR   2018-2022: 6.9%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Application, End User.
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   GE Healthcare, Siemens Healthcare, Koninklijke Philips N.V., Bruker Corporation, Mediso Ltd., Digirad Corporation, Spectrum Dynamics Medical, DDD-Diagnostic A/S, MiE America, Inc., CardiArc, Beijing Hamamatsu Photon Techniques INC., SHENZHEN BASDA MEDICAL APPARATUS CO., LTD. PNPMedM, NuCare Inc
  Key Market Opportunities   Increasing awareness of disease-causing deformities along with the rise in the number of numerous surgeries
  Key Market Drivers

  • Growing geriatric population
  • Improvements in spect imaging technology
  • Shorter half-life of radioisotopes
  • Huge capital investment, and stringent regulatory guidelines


  • Speak to Analyst Ask for Customization